The Elusive Battle: Millions Still Dying from TB Despite Progress

Tuberculosis (TB) has regained its position as the world's leading infectious disease killer, surpassing COVID-19, with 40% of people living with TB remaining untreated and undiagnosed. Despite recent advancements in diagnosing and treating TB, including new medicines and better diagnostic tools, millions of people are still dying from the disease. The lack of personnel, funding, and resources in many developing countries hinders the implementation of effective TB screening and treatment programs. While there is hope for an effective TB vaccine and progress in making medications more affordable, greater investment and commitment are needed to reach neglected communities and achieve the goal of ending TB.